Liangbo Shen, MD, discussed unmet needs in geographic atrophy and how implants could ease treatment burden.
Commentary|Articles|July 28, 2026
Beyond the trials: Pegcetacoplan slows GA progression in eyes with concurrent nAMD
Hasenin Al-khersan, MD, of the Retina Group of Florida, shares real-world RCA registry findings showing that pegcetacoplan significantly reduced both photoreceptor and RPE loss in eyes with GA.
Advertisement
Advertisement
Related to this article
Jordi Monés, MD, PhD, explains why RP and Stargardt data support testing son-vec to restore vision in advanced GA.
At AAO 2026, Adam, MD, shares Yamane technique pearls, from docking the trailing haptic to preventing tilt and haptic exposure.
Andrew G. Lee, MD, and Drew Carey, MD, break down the link between optic neuritis and uveitis in central nervous system demyelinating disease.
Anat Galor, MD, MSPH, discusses subtyping dry eye, emerging diagnostic tools, and when to consider oral neuromodulation.
At AAO 2026, Anjum F. Koreishi, MD, shared how to prevent complications after cataract surgery in patients with uveitis.
David F. Chang, MD, shares how to set realistic refractive IOL expectations and streamline patient counseling.
Timothy Janetos, MD, explained when to refer uveitis to a specialist and why access to uveitis care remains limited.
Advertisement
Advertisement